Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern
Recommend:
0

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
Recommend :
0
React to this article
Latest news
Date Title
<1m ago LVMH : Alicia Keys discusses new Givenchy perfume 'Dahlia Divin'
<1m ago U.S. MANUFACTURING SECTOR ACCELERATES IN AUGUST : Ism
<1m ago RESEARCH AND MARKETS : Global In-Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020
1m ago WINTRUST FINANCIAL : to Present at the Raymond James 2014 U.S. Bank Conference
1m ago AICPA to Release Results of CPA Economic Outlook Index on Thursday, September 4
1m ago GUMGUM : Strengthens Management Team With Appointment of Industry Veteran Mike Rosner as Chief Revenue Officer
1m ago GIANT TIGER STORES LIMITED : Announces New Store in Timmins, ON
2m ago David J. Cohen, MD, M.Sc. and John A. Spertus, MD, MPH, of Saint Luke's Mid America Heart Institute, Named as Two of the World's Most Influential Scientific Minds 2014
2m ago REACH HEALTH : Reports 113 Percent Growth in Monthly Consult Volumes
3m ago HOME FINANCIAL BANCORP : Announces Dividend
Latest news
Advertisement
Hot News 
CORRECT : Dixons Carphone Confirms Long Term Deal With Vodafone
TMM REAL ESTATE DEVELOPMENT : Sonyachna Brama residential complex construction status update
EXELIXIS : Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in Men with Metastatic Castration-Resistant Prostate Cancer
MATTIOLI WOODS : Raises Dividend As Profit Grows, Revenue Mix Shifts
CRANEWARE : Issue of Consideration Shares
Most Read News
1d ago FORMFACTOR : Raises Third Quarter Guidance Range
1d ago STUART OLSON : announces sale of Broda Construction
1d ago MEDICINOVA : to Present Data on MN-001 (tipelukast) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) During the 18th International Colloquium on Lung and Airway Fibrosis (ICLAF)
1d ago EXELIXIS : Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in Men with Metastatic Castration-Resistant Prostate Cancer
8h ago MANCHESTER UNITED : Van Gaal Speaks on Di Maria Injury
Most recommended articles
1d agoDJZambia Copper Miners Say Crippled by Unpaid $600 Million Tax Refund-Mines Body
4d ago S&P 500 edges up to set new record; best month since Feb
7m agoUNITED STATES : Construction Spending better than estimates at 1.8%
7m agoUNITED STATES : ISM Manufacturing PMI better than estimates at 59.0
17m ago Halliburton to settle U.S. Gulf spill claims for $1.1 billion
Dynamic quotes  
ON
| OFF